Prof Benjamin A. Toll

Professor of Public Health Sciences & Psychiatry

Medical University of South Carolina


Dr. Benjamin Toll is a licensed clinical psychologist, a Professor of Public Health Sciences and Psychiatry, the Vice Chair of Research for the Department of Public Health Sciences, and the Associate Director of Education and Training and Co-Director of the Lung Cancer Screening Program at MUSC Hollings Cancer Center, and Director of the MUSC Health Tobacco Treatment Program at the Medical University of South Carolina.

Dr. Toll has received grants from the US National Institutes of Health, including multiple R01 grants from the National Cancer Institute, and he is an author of 145 peer-reviewed publications relating to nicotine and tobacco research, including several large clinical trials investigating smoking cessation published in first tier medical (e.g., Journal of the National Cancer Institute, Journal of Thoracic Oncology) and psychology journals (e.g., Journal of Consulting and Clinical Psychology) and several pilot clinical trials testing treatments for e-cigarette use. Moreover, Dr. Toll has published multiple papers in first tier medical journals using nationally representative data showing that most e-cigarette users plan to quit vaping (in JAMA Network Open, Tobacco Control) and that e-cigarettes are used more than cigarettes by 18-24 year-olds in the US (in JAMA Internal Medicine), forecasting a future in which e-cigarettes are the dominant tobacco product in the US. He has 20 articles published in high-impact journals (Impact Factor > 10), including multiple Clinical Practice Guidelines and official policy statements from major medical associations. He has served as an author for the American Association for Cancer Research (AACR) policy statement encouraging physicians to provide tobacco treatment for cancer patients, the American Thoracic Society’s (ATS) Clinical Practice Guideline for treatment of tobacco dependent adults, and the AACR and American Society of Clinical Oncology (ASCO) policy statement on Electronic Nicotine Delivery Systems (ENDS). He is currently Co-Chairing a Clinical Practice Guideline for CHEST that will focus on treatment guidelines for hospitalized patients who smoke. He holds leadership positions in national associations relating to nicotine and tobacco research. Dr. Toll is the President of the Society for Research on Nicotine and Tobacco (SRNT) and a member of the AACR Tobacco and Cancer Subcommittee.

« Back